Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease

Current therapies have not shown benefit in organ damage reversal in Fabry disease (FD), but biomarkers could help risk stratification and prognosis. We investigated if several biomarkers of cardiac fibrosis, cardiac wall stress, myocardial injury, renal function and inflammation, are associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-Romero, Diana, Sánchez-Quiñones, Jessica, Vílchez, Juan Antonio, Rivera-Caravaca, José Miguel, de la Morena, Gonzalo, Lip, Gregory Y. H., Climent, Vicente, Marín, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470309/
https://www.ncbi.nlm.nih.gov/pubmed/30996283
http://dx.doi.org/10.1038/s41598-019-42727-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470309/
https://www.ncbi.nlm.nih.gov/pubmed/30996283
http://dx.doi.org/10.1038/s41598-019-42727-4

Ejemplares similares